Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Hirvonen, J. Articles by Hietala, J. Search for Related Content PubMed Citation Articles by Hirvonen, J. Articles by Hietala, J. Schizophrenia Spectrum Disorders Genetics PET Related Article

Brain Dopamine D₁ Receptors in Twins Discordant for Schizophrenia

OBJECTIVE: It has been suggested that deficits in higher-order cognitive functions serve as intermediate phenotypic indicators of genetic vulnerability to schizophrenia. The dopamine hypothesis of schizophrenia postulates that insufficiency of dopamine transmission in the prefrontal cortex contributes to the cognitive deficits observed in patients with the disease, and there is robust empirical evidence for a central role of prefrontal cortex dopamine D₁ receptors in working memory functions. METHOD: The authors examined the genetic and nongenetic effects on D₁ receptor binding in schizophrenia by studying monozygotic and dizygotic twin pairs discordant for schizophrenia as well as healthy comparison twins using positron emission tomography (PET) and the D₁ receptor antagonist ligand [¹¹C]SCH 23390. Performance on neuropsychological tests sensitive to frontal lobe functioning was evaluated. RESULTS: High D₁ receptor density in the medial prefrontal cortex, superior temporal gyrus, and heteromodal association cortex (angular gyrus) was associated with increasing genetic risk for schizophrenia (comparison twins < unaffected dizygotic co-twins < unaffected monozygotic co-twins). Medicated schizophrenia patients demonstrated a widespread reduction in D₁ receptor binding when compared with the unaffected co-twin, and higher doses of antipsychotics were associated with lower D₁ receptor binding in the frontotemporal regions. CONCLUSIONS: This study demonstrated an association between genetic risk for schizophrenia and alterations in cortical D₁ receptor binding, an observation that has implications for future studies of the molecular genetics of schizophrenia. In addition, the data indicate a widespread reduction of D₁ receptor binding in medicated schizophrenia patients, supporting a link between antipsychotic drug action and dopamine D₁ receptor down-regulation.

Related Article:

In This Issue
Am J Psychiatry 2006 163: A62. [Full Text] [PDF]

This article has been cited by other articles:

				Dopamine-1 Receptors and Schizophrenia Journal Watch Psychiatry, November 13, 2006; 2006(1113): 4 - 4. [Full Text]

Get information about faster international access.

Privacy Policy

Copyright © 2006 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us